S. Lee-huang et al., Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin, P NAS US, 96(6), 1999, pp. 2678-2681
Citations number
21
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Human chorionic gonadotropin (hCG) preparations contain activity against HI
T: type 1 (HIV-1). However, there has been controversy about whether some b
iological activities of hCG beta-subunit (hCG beta) preparations are caused
by the beta-subunit itself or other proteins present in the preparations,
We report here the purification, characterization, and identification of th
ree enzymes with anti-HIV activity present in the beta-core fraction of hCG
beta prepared from the urine of pregnant women. The N-terminal amino acid
sequence of one protein is identical to human urinary lysozyme C, and those
of the other two are identical to human RNase A and urinary RNase U. We th
us refer to these proteins as AVL (antiviral lysozyme) and AVR (antiviral R
Nases). In addition to HIV-1 inhibition, AVL is capable of lysing Micrococc
us lysodeikticus. AVR digests a variety of RNA substrates, including RNA fr
om HIV-1-infected cells. We also find that lysozyme from chicken egg white,
human milk and human neutrophils and RNase A from bovine pancreas possess
activity against HIV-I. These findings may offer additional strategies for
the treatment of HIV-1 infection.